Lonza Group AG (LZAGY)
65.44
-0.42 (-0.64%)
At close: Apr 14, 2025, 3:57 PM
-0.64% (1D)
| Bid | 64.77 |
| Market Cap | 47.21B |
| Revenue (ttm) | 6.7B |
| Net Income (ttm) | 573M |
| EPS (ttm) | 1.04 |
| PE Ratio (ttm) | 62.92 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 65.37 |
| Volume | 18,535 |
| Avg. Volume (20D) | 66,686 |
| Open | 64.09 |
| Previous Close | 65.86 |
| Day's Range | 63.91 - 65.44 |
| 52-Week Range | 52.23 - 68.29 |
| Beta | 0.84 |
About LZAGY
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia and New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals fo...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jan 20, 2010
Employees 17,995
Stock Exchange PNK
Ticker Symbol LZAGY
Website https://www.lonza.com
